|
Volumn , Issue 2, 2003, Pages
|
Alpha2 adrenergic agonists for the management of opioid withdrawal.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR;
METHADONE;
NARCOTIC AGENT;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ACUTE DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
WITHDRAWAL SYNDROME;
DRUG POTENTIATION;
META ANALYSIS;
ACUTE DISEASE;
CONTROLLED CLINICAL TRIALS;
HUMANS;
METHADONE;
NARCOTICS;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ADRENERGIC, ALPHA-2;
SUBSTANCE WITHDRAWAL SYNDROME;
ADRENERGIC ALPHA-AGONISTS;
|
EID: 84921705631
PISSN: None
EISSN: 1469493X
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (27)
|
References (88)
|